The global Blood Screening Market was valued at USD 1.54 billion in 2016 and is projected to reach USD 3.63 billion by 2025, growing at a CAGR of 10% from 2017 to 2025.
A blood screening is a medical process in which blood is scanned to test for a particular disease or condition. These processes vary according to the medical procedure to be performed. Increasing incidences of blood donation or transfusion is the key factor which is increasing the need of blood screening hence causing the market to grow rapidly.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing numbers of blood transfusions and donation cases
1.2 Increasing need of blood donation and transfusions
1.3 Growing number of infections
1.4 Safety awareness increment regarding blood donation
2. Market Restraints
2.1 Capital expenditure
2.2 Lack of regulations
2.3 Alternatives available
Market Segmentation:
1. Global Blood Screening Market, by Product and Services:
1.1 Reagents & Kits
1.1.1 NAT Reagents & Kits
1.1.1.1 Enzymes and Polymerases
1.1.1.2 Standards and Controls
1.1.1.3 Probes and Primers
1.1.1.4 Buffers, Nucleotides and Solutions
1.1.1.5 Labeling and Detection Reagents
1.1.2 ELISA Reagents & Kits
1.1.2.1 Immunosorbents
1.1.2.2 Controls
1.1.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
1.1.2.4 Substrates (Of Enzymes)
1.1.2.5 Sample Diluents and Wash Solutions
1.1.3 Other Reagents
1.2 Instruments
1.2.1 Rental Purchase
1.2.2 Outright Purchase
1.3 Software and Services
2. Global Blood Screening Market, by End User:
2.1 Blood Banks
2.2 Hospitals
3. Global Blood Screening Market, by Technology:
3.1 Nucleic Acid Test (NAT)
3.1.1 Transcription-Mediated Amplification (TMA)
3.1.2 Real-Time Polymerase Chain Reaction (PCR)
3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
3.2.1 ELISA Market, By Platform
3.2.1.1 Chemiluminescence Immunoassay (CLIA)
3.2.1.2 Fluorescence Immunoassay (FIA)
3.2.1.3 Colorimetric Immunoassay (CI)
3.2.2 ELISA Market, By Generation
3.2.2.1 First-Generation ELISA
3.2.2.2 Second-Generation ELISA
3.2.2.3 Third-Generation ELISA
3.2.2.4 Fourth-Generation & Above
3.3 Rapid Tests
3.4 Western Blot Assay
3.5 Next-Generation Sequencing (NGS)
4. Global Blood Screening Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Grifols
2. F. Hoffmann-La Roche
3. Abbott Laboratories
4. Biomérieux
5. Bio-Rad Laboratories, Inc.
6. Siemens Healthineers (A Subsidiary of Siemens AG)
7. Ortho Clinical Diagnostics, Inc.
8. Thermo Fisher Scientific, Inc.
9. Beckman Coulter (A Subsidiary of Danaher Corporation)
10. Becton, Dickinson and Company
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Blood Screening Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BLOOD SCREENING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BLOOD SCREENING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Blood Screening Market, by Product and Services:
5.1 Reagents & Kits
5.1.1 NAT Reagents & Kits
5.1.1.1 Enzymes and Polymerases
5.1.1.2 Standards and Controls
5.1.1.3 Probes and Primers
5.1.1.4 Buffers, Nucleotides and Solutions
5.1.1.5 Labeling and Detection Reagents
5.1.2 ELISA Reagents & Kits
5.1.2.1 Immunosorbents
5.1.2.2 Controls
5.1.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
5.1.2.4 Substrates (Of Enzymes)
5.1.2.5 Sample Diluents and Wash Solutions
5.1.3 Other Reagents
5.2 Instruments
5.2.1 Rental Purchase
5.2.2 Outright Purchase
5.3 Software and Services
6 Global Blood Screening Market, by End User:
6.1 Blood Banks
6.2 Hospitals
7 Global Blood Screening Market, by Technology:
7.1 Nucleic Acid Test (NAT)
7.1.1 Transcription-Mediated Amplification (TMA)
7.1.2 Real-Time Polymerase Chain Reaction (PCR)
7.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.1 ELISA Market, By Platform
7.2.1.1 Chemiluminescence Immunoassay (CLIA)
7.2.1.2 Fluorescence Immunoassay (FIA)
7.2.1.3 Colorimetric Immunoassay (CI)
7.2.2 ELISA Market, By Generation
7.2.2.1 First-Generation ELISA
7.2.2.2 Second-Generation ELISA
7.2.2.3 Third-Generation ELISA
7.2.2.4 Fourth-Generation & Above
7.3 Rapid Tests
7.4 Western Blot Assay
7.5 Next-Generation Sequencing (NGS)
8 GLOBAL BLOOD SCREENING MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL BLOOD SCREENING MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Grifols
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 F. Hoffmann-La Roche
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Abbott Laboratories
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Biomerieux
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Siemens Healthineers
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Ortho Clinical Diagnostics, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Thermo Fisher Scientific, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Beckman Coulter
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Becton, Dickinson and Company
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports
The Protein Drug Screening Validation Database Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The AI-Driven Psychological Screening Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Blood Bank Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Market Overview
The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...
Market Overview
The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...
Market Overview
The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...
Market Overview
The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...
Market Overview
The North America Ambulance Equipment Market is expected to witness robust growth from 2024 to 2034, driven by the increasing incidence of medical emergencies, advancements in medical technologies, and the expanding healthcare infrastructure. By 2034, the market is proje...